コンパニオンアニマル診断薬の市場規模および予測（2020年～2030年）、世界および地域シェア、動向、成長機会分析レポートの対象範囲技術別（免疫診断、臨床生化学、分子診断、尿検査、血液学、その他）、製品別（機器と消耗品）、用途別（細菌学、臨床病理学、ウイルス学、寄生虫学、その他）、コンパニオンアニマルタイプ（犬、猫、馬、その他）、エンドユーザー（診断ラボ、動物病院・クリニック、研究機関、その他）、地域（北米、欧州、アジア太平洋、南米・中米、中東・アフリカ）

Companion Animal Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Technique (Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Urinalysis, Hematology, and Others), Product (Instruments and Consumables), Application (Bacteriology, Clinical Pathology, Virology, Parasitology, and Others), Companion Animal Type (Dogs, Cats, Horses, and Others), End User (Diagnostic Laboratories, Veterinary Hospitals and Clinics, Research Institutes, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

コンパニオンアニマル診断薬市場は、2022年の31億3,900万米ドルから2030年には63億300万米ドルに成長すると予想され、2022年から2030年までの年平均成長率は9.1%を記録すると予測されている。コンパニオンア... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年11月2日	US$4,550 シングルユーザライセンスライセンス・価格情報注文方法はこちら	241	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

コンパニオンアニマル診断薬市場は、2022年の31億3,900万米ドルから2030年には63億300万米ドルに成長すると予想され、2022年から2030年までの年平均成長率は9.1%を記録すると予測されている。

コンパニオンアニマル診断製品は、ペット動物の様々な疾病の診断を行う。これらの製品は、家畜の疫学と病因を扱い、飼い主だけでなくペットの健康の更なる合併症を防ぐ。これらの製品は通常、猫、犬、馬などの動物に使用されます。コンパニオンアニマル診断薬の市場規模は、感染症の症例数の増加や、動物の病気を検出するためのポイントオブケア診断薬の使用に関する意識の高まりとともに拡大している。ポイントオブケア診断薬（POCDs）は、現場レベルで病気の状態を検出することができるシンプルで迅速なポータブル診断装置である。近年、リアルタイムPCR（qPCR）がPOCDプラットフォームに移行している。これらの完全に自動化されたプラットフォームは、核酸抽出、サーマルサイクリング、現場での結果報告を兼ね備えている。例えば、エニグマ・ダイアグノスティックス社のMiniLabは10-35kgの分子診断プラットフォームで、現場レベルで携帯され、アフリカ豚熱ウイルス、古典的豚熱ウイルス、鳥インフルエンザウイルス、口蹄疫ウイルスを研究目的で検証するために使用される。英国Primerdesign社のgenesig検出キットは、研究目的でウシ62種、ウマ42種、ブタ47種、鳥類60種、イヌ40種、ネコ26種の病原体を診断するための凍結乾燥qPCRアッセイキットを供給している。

ペットへの支出の増加がコンパニオンアニマル診断薬市場の成長を牽引

ペットの飼い主の多くは、動物のヘルスケア、特に獣医学的ケア、診断、医薬品に多額の出費をしている。ペットの健康管理と予防診断検査は、まだ初期段階にある。動物も人間と同様、関節炎、癌、アレルギーなどの慢性疾患に悩まされることがある。ペットの慢性疾患はより一般的になってきており、ペットの幸福と健康に対する人々の支出に大きな影響を及ぼしている。米国獣医師会の推計によると、犬の4頭に1頭は、生涯のどこかで新形成を経験する可能性があるという。さらに、半数近くの犬が10歳以降にガンを発症するという。米国ペット用品協会によると、2022年に米国人がペットに費やした金額は1368億米ドルで、2021年の金額（1236億米ドル）を10.68％上回った。このように、慢性疾患の蔓延が、ペット支出増加のより大きな要因となっている。例えば、世界のHealthforAnimalsによると、2022年にはコンパニオンアニマルの診断に推定46億米ドルが費やされた。

図：米国におけるペット産業支出、2012-2021年

出典米国ペット用品協会の2021-2022年全国ペットオーナー調査

コンパニオンアニマル診断市場は、技術、製品、用途、コンパニオンアニマルタイプ、エンドユーザー、地域によって区分されます。技術別では、コンパニオンアニマル診断市場は免疫診断、臨床生化学、血液学、尿検査、分子診断、その他に区分される。免疫診断分野は、ラテラルフローアッセイ、ELISA検査、アレルゲン特異的免疫診断検査、イムノアッセイ・アナライザーに細分される。臨床生化学分野はさらに臨床化学分析、グルコースモニタリング、血液ガス電解質分析に分類される。コンパニオンアニマル診断市場は、製品別に機器と消耗品に二分される。用途別では、コンパニオンアニマル診断市場は細菌学、臨床病理学、ウイルス学、寄生虫学、その他に区分される。コンパニオンアニマルタイプ別では、コンパニオンアニマル診断市場は犬、猫、馬、その他に区分される。エンドユーザー別では、コンパニオンアニマル診断市場は、診断ラボ、動物病院・診療所、研究機関・大学に区分される。

地域別では、北米、欧州、アジア太平洋、中東・アフリカ、中南米に区分される。コンパニオンアニマル診断市場は北米が最大の市場シェアを占めている。同地域における市場の成長は、獣医学における研究開発活動に対する政府支援の増加、様々な市場統合をもたらす技術進歩の成長、および北米各国におけるペット動物の導入の増加によるものである。加えて、コンパニオンアニマル診断薬市場における様々なマーケットリーダーの存在は、予測期間中の市場成長にプラスの影響を与えると予測されます。コンパニオンアニマル診断市場は米国が北米で最大となる見込みです。同国における市場の成長は、獣医分野の研究開発における技術的に先進的なチームや、多数の動物保健センターの存在といった要因によって決定されます。これに加えて、ペット動物の飼育率の上昇とペットの健康維持に対する関心の高まりが、市場の成長をさらに促進している。米国動物愛護協会（Humane Society of the United States）によると、2021年と2022年には、それぞれ推定6,900万世帯と4,540万世帯が少なくとも1匹の犬と猫を飼っている。米国ペット用品協会によると、アメリカ人は2022年に1368億米ドルをペットに費やし、2021年（＝1236億米ドル）から10.68％増加した。

米国では、特定の動物用診断薬は規制されており、米国農務省-動物用生物製剤センター（USDA-CVB）の承認に依存している。これには、治療中の動物の病原体を診断するための動物用診断キットが含まれる。USDA-CVBは、猫白血病ウイルス（FeLV）、犬パルボウイルス、犬回虫、およびその他のウイルスを検査するためのポイントオブケア診断薬です。National Veterinary Services Laboratoriesは、動物の診断サービスを提供しており、家畜や外国の動物の病気の診断を中心に、幅広い診断サービスと情報を提供している。この研究所はまた、疾病管理および撲滅プログラムの支援にも携わっている。また、診断検査用試薬の製造やトレーニング、検査資格の取得も行っている。同様に、American Association of Veterinary Laboratory Diagnosticiansに加盟している私立研究所もある。例えば、Wisconsin Veterinary Diagnostic Laboratoryは、畜産、コンパニオンアニマル、エキゾチックアニマルの業界に幅広い診断サービスを提供している。

米国には有力企業が存在し、市場の成長をさらに促進している。例えば、Zoetis Inc.は、動物用ポイントオブケア診断機器と消耗品の開発、製造、販売に携わる市場リーダーの一社である。また、抗原抗体反応によるウイルス、細菌、ウイルスに対する抗体、細菌の検出を支援する免疫診断製品も提供している。

カナダにおけるコンパニオンアニマル用診断薬市場は、医療制度が整備され、構造化されていることから成長が見込まれている。カナダ政府は、より良いサービスを提供するための規制を実施することで、獣医部門を支援している。例えば、カナダにおける動物用生物製剤の規制のガイドライン4.10Eでは、動物用生物製剤（VB）のためのカナダ動物用生物製剤センター（CCVB）規制プログラムが実施されている。動物の健康法および規則の権限により、このプログラムが課された。VB規制プログラムは、家畜、家禽、コンパニオンアニマル、野生動物、水生種など、カナダの動物の健康を守ることを目的としている。さらに、動物固有の病気をコントロールし、外来動物の病気の蔓延を防ぐことによって、公衆衛生と食品の安全を守ることも目的としています。

同様に、カナダ政府によるイニシアチブの増加が、同国における市場成長をさらに後押ししている。例えば、アニマルヘルス・カナダは、カナダの動物疾病予防と動物衛生管理の能力強化に取り組んでいる。さらに、マース・ペットケア社の一部門であるアンテック・ダイアグノスティックス社は、動物の健康診断と農業診断に特化したカナダのバイオテクノロジー企業であるバイオベット社を買収した。この買収により、アンテック・ダイアグノスティックスの研究能力が拡大し、カナダ全土の獣医師がアクセスできるようになると期待されている。さらに、様々な人獣共通感染症の蔓延の増加、技術の進歩、ペット飼育の増加が、カナダでの市場成長を促進する要因となっている。

American Horse Council、Centers for Disease Control and Prevention (CDC)、World Health Organization (WHO)、National Council of Societies for the Prevention of Cruelty to Animals (NSPCA)はコンパニオンアニマル診断市場に関するレポート作成時に参照したいくつかの主要な一次および二次情報源です。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Companion Animal Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Companion Animal Diagnostics Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Adoption of Pets for Companionship
5.1.2 Upsurge in Pet Spending
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 New Product Launches and Approvals
5.4 Future Trends
5.4.1 Technological Advancements
5.5 Impact Analysis
6. Companion Animal Diagnostics Market - Global Market Analysis
6.1 Companion Animal Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Global Companion Animal Diagnostics Market – Revenue and Forecast to 2030 – by Technique
7.1 Overview
7.2 Companion Animal Diagnostics Market Revenue Share, by Technique 2022 & 2030 (%)
7.3 Immunodiagnostics
7.3.1 Overview
7.3.2 Immunodiagnostics: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Immunodiagnostics: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Clinical Biochemistry
7.4.1 Overview
7.4.2 Clinical Biochemistry: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Clinical Biochemistry: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Molecular Diagnostics
7.5.1 Overview
7.5.2 Molecular Diagnostics: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Molecular Diagnostics: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Urinalysis
7.6.1 Overview
7.6.2 Urinalysis: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Hematology
7.7.1 Overview
7.7.2 Hematology: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Companion Animal Diagnostics Market – Revenue and Forecast to 2030 – by Product
8.1 Overview
8.2 Companion Animal Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
8.3 Instruments
8.3.1 Overview
8.3.2 Instruments: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Consumables
8.4.1 Overview
8.4.2 Consumables: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Companion Animal Diagnostics Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 Companion Animal Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Bacteriology
9.3.1 Overview
9.3.2 Bacteriology: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Clinical Pathology
9.4.1 Overview
9.4.2 Clinical Pathology: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Virology
9.5.1 Overview
9.5.2 Virology: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Parasitology
9.6.1 Overview
9.6.2 Parasitology: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Companion Animal Diagnostics Market – Revenue and Forecast to 2030 – by Companion Animal Type
10.1 Overview
10.2 Companion Animal Diagnostics Market Revenue Share, by Companion Animal Type 2022 & 2030 (%)
10.3 Dogs
10.3.1 Overview
10.3.2 Dogs: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Cats
10.4.1 Overview
10.4.2 Cats: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Horses
10.5.1 Overview
10.5.2 Horses: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. Global Companion Animal Diagnostics Market – Revenue and Forecast to 2030 – by End User
11.1 Overview
11.2 Companion Animal Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
11.3 Diagnostic Laboratories
11.3.1 Overview
11.3.2 Diagnostic Laboratories: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.4 Veterinary Hospitals and Clinics
11.4.1 Overview
11.4.2 Veterinary Hospitals and Clinics: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.5 Research Institutes
11.5.1 Overview
11.5.2 Research Institutes: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.6 Others
11.6.1 Overview
11.6.2 Others: Companion Animal Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
12. Companion Animal Diagnostics Market - Geographical Analysis
12.1 North America Companion Animal Diagnostics Market, Revenue And Forecast To 2030
12.1.1 Overview
12.1.2 North America Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.3 North America Companion Animal Diagnostics Market, by Technique
12.1.3.1 North America: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.1.3.2 North America: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.1.3.3 North America: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.1.4 North America Companion Animal Diagnostics Market, by Product
12.1.5 North America Companion Animal Diagnostics Market, by Application
12.1.6 North America Companion Animal Diagnostics Market, by Companion Animal Type
12.1.7 North America Companion Animal Diagnostics Market, by End User
12.1.8 North America Companion Animal Diagnostics Market, by Country
12.1.8.1 US
12.1.8.1.1 Overview
12.1.8.1.2 US Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.8.1.3 US Companion Animal Diagnostics Market, by Technique
12.1.8.1.3.1 US: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.1.8.1.3.2 US: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.1.8.1.3.3 US: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.1.8.1.4 US Companion Animal Diagnostics Market, by Product
12.1.8.1.5 US Companion Animal Diagnostics Market, by Application
12.1.8.1.6 US Companion Animal Diagnostics Market, by Companion Animal Type
12.1.8.1.7 US Companion Animal Diagnostics Market, by End User
12.1.8.2 Canada
12.1.8.2.1 Overview
12.1.8.2.2 Canada Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.8.2.3 Canada Companion Animal Diagnostics Market, by Technique
12.1.8.2.3.1 Canada: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.1.8.2.3.2 Canada: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.1.8.2.3.3 Canada: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.1.8.2.4 Canada Companion Animal Diagnostics Market, by Product
12.1.8.2.5 Canada Companion Animal Diagnostics Market, by Application
12.1.8.2.6 Canada Companion Animal Diagnostics Market, by Companion Animal Type
12.1.8.2.7 Canada Companion Animal Diagnostics Market, by End User
12.1.8.3 Mexico
12.1.8.3.1 Overview
12.1.8.3.2 Mexico Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.8.3.3 Mexico Companion Animal Diagnostics Market, by Technique
12.1.8.3.3.1 Mexico: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.1.8.3.3.2 Mexico: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.1.8.3.3.3 Mexico: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.1.8.3.4 Mexico Companion Animal Diagnostics Market, by Product
12.1.8.3.5 Mexico Companion Animal Diagnostics Market, by Application
12.1.8.3.6 Mexico Companion Animal Diagnostics Market, by Companion Animal Type
12.1.8.3.7 Mexico Companion Animal Diagnostics Market, by End User
12.2 Europe Companion Animal Diagnostics Market, Revenue and Forecast to 2030
12.2.1 Overview
12.2.2 Europe Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.3 Europe Companion Animal Diagnostics Market, by Technique
12.2.3.1 Europe: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.2.3.2 Europe: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.2.3.3 Europe: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.2.4 Europe Companion Animal Diagnostics Market, by Product
12.2.5 Europe Companion Animal Diagnostics Market, by Application
12.2.6 Europe Companion Animal Diagnostics Market, by Companion Animal Type
12.2.7 Europe Companion Animal Diagnostics Market, by End User
12.2.8 Europe Companion Animal Diagnostics Market by Country
12.2.8.1 Germany
12.2.8.1.1 Overview
12.2.8.1.2 Germany Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.1.3 Germany Companion Animal Diagnostics Market, by Technique
12.2.8.1.3.1 Germany: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.2.8.1.3.2 Germany: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.2.8.1.3.3 Germany: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.2.8.1.4 Germany Companion Animal Diagnostics Market, by Product
12.2.8.1.5 Germany Companion Animal Diagnostics Market, by Application
12.2.8.1.6 Germany Companion Animal Diagnostics Market, by Companion Animal Type
12.2.8.1.7 Germany Companion Animal Diagnostics Market, by End User
12.2.8.2 UK
12.2.8.2.1 Overview
12.2.8.2.2 UK Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.2.3 UK Companion Animal Diagnostics Market, by Technique
12.2.8.2.3.1 UK: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.2.8.2.3.2 UK: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.2.8.2.3.3 UK: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.2.8.2.4 UK Companion Animal Diagnostics Market, by Product
12.2.8.2.5 UK Companion Animal Diagnostics Market, by Application
12.2.8.2.6 UK Companion Animal Diagnostics Market, by Companion Animal Type
12.2.8.2.7 UK Companion Animal Diagnostics Market, by End User
12.2.8.3 France
12.2.8.3.1 Overview
12.2.8.3.2 France Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.3.3 France Companion Animal Diagnostics Market, by Technique
12.2.8.3.3.1 France: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.2.8.3.3.2 France: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.2.8.3.3.3 France: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.2.8.3.4 France Companion Animal Diagnostics Market, by Product
12.2.8.3.5 France Companion Animal Diagnostics Market, by Application
12.2.8.3.6 France Companion Animal Diagnostics Market, by Companion Animal Type
12.2.8.3.7 France Companion Animal Diagnostics Market, by End User
12.2.8.4 Italy
12.2.8.4.1 Overview
12.2.8.4.2 Italy Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.4.3 Italy Companion Animal Diagnostics Market, by Technique
12.2.8.4.3.1 Italy: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.2.8.4.3.2 Italy: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.2.8.4.3.3 Italy: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.2.8.4.4 Italy Companion Animal Diagnostics Market, by Product
12.2.8.4.5 Italy Companion Animal Diagnostics Market, by Application
12.2.8.4.6 Italy Companion Animal Diagnostics Market, by Companion Animal Type
12.2.8.4.7 Italy Companion Animal Diagnostics Market, by End User
12.2.8.5 Spain
12.2.8.5.1 Overview
12.2.8.5.2 Spain Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.5.3 Spain Companion Animal Diagnostics Market, by Technique
12.2.8.5.3.1 Spain: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.2.8.5.3.2 Spain: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.2.8.5.3.3 Spain: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.2.8.5.4 Spain Companion Animal Diagnostics Market, by Product
12.2.8.5.5 Spain Companion Animal Diagnostics Market, by Application
12.2.8.5.6 Spain Companion Animal Diagnostics Market, by Companion Animal Type
12.2.8.5.7 Spain Companion Animal Diagnostics Market, by End User
12.2.8.6 Rest of Europe
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.2.8.6.3 Rest of Europe Companion Animal Diagnostics Market, by Technique
12.2.8.6.3.1 Rest of Europe: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.2.8.6.3.2 Rest of Europe: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.2.8.6.3.3 Rest of Europe: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.2.8.6.4 Rest of Europe Companion Animal Diagnostics Market, by Product
12.2.8.6.5 Rest of Europe Companion Animal Diagnostics Market, by Application
12.2.8.6.6 Rest of Europe Companion Animal Diagnostics Market, by Companion Animal Type
12.2.8.6.7 Rest of Europe Companion Animal Diagnostics Market, by End User
12.3 Asia Pacific Companion Animal Diagnostics Market, Revenue And Forecast to 2030
12.3.1 Overview
12.3.2 Asia Pacific Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.3 Asia Pacific Companion Animal Diagnostics Market, by Technique
12.3.3.1 Asia Pacific: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.3.3.2 Asia Pacific: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.3.3.3 Asia Pacific: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.3.4 Asia Pacific Companion Animal Diagnostics Market, by Product
12.3.5 Asia Pacific Companion Animal Diagnostics Market, by Application
12.3.6 Asia Pacific Companion Animal Diagnostics Market, by Companion Animal Type
12.3.7 Asia Pacific Companion Animal Diagnostics Market, by End User
12.3.8 Asia Pacific Companion Animal Diagnostics Market by Country
12.3.8.1 China
12.3.8.1.1 Overview
12.3.8.1.2 China Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.1.3 China Companion Animal Diagnostics Market, by Technique
12.3.8.1.3.1 China: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.3.8.1.3.2 China: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.3.8.1.3.3 China: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.3.8.1.4 China Companion Animal Diagnostics Market, by Product
12.3.8.1.5 China Companion Animal Diagnostics Market, by Application
12.3.8.1.6 China Companion Animal Diagnostics Market, by Companion Animal Type
12.3.8.1.7 China Companion Animal Diagnostics Market, by End User
12.3.8.2 Japan
12.3.8.2.1 Overview
12.3.8.2.2 Japan Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.2.3 Japan Companion Animal Diagnostics Market, by Technique
12.3.8.2.3.1 Japan: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.3.8.2.3.2 Japan: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.3.8.2.3.3 Japan: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.3.8.2.4 Japan Companion Animal Diagnostics Market, by Product
12.3.8.2.5 Japan Companion Animal Diagnostics Market, by Application
12.3.8.2.6 Japan Companion Animal Diagnostics Market, by Companion Animal Type
12.3.8.2.7 Japan Companion Animal Diagnostics Market, by End User
12.3.8.3 India
12.3.8.3.1 Overview
12.3.8.3.2 India Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.3.3 India Companion Animal Diagnostics Market, by Technique
12.3.8.3.3.1 India: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.3.8.3.3.2 India: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.3.8.3.3.3 India: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.3.8.3.4 India Companion Animal Diagnostics Market, by Product
12.3.8.3.5 India Companion Animal Diagnostics Market, by Application
12.3.8.3.6 India Companion Animal Diagnostics Market, by Companion Animal Type
12.3.8.3.7 India Companion Animal Diagnostics Market, by End User
12.3.8.4 Australia
12.3.8.4.1 Overview
12.3.8.4.2 Australia Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.4.3 Australia Companion Animal Diagnostics Market, by Technique
12.3.8.4.3.1 Australia: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.3.8.4.3.2 Australia: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.3.8.4.3.3 Australia: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.3.8.4.4 Australia Companion Animal Diagnostics Market, by Product
12.3.8.4.5 Australia Companion Animal Diagnostics Market, by Application
12.3.8.4.6 Australia Companion Animal Diagnostics Market, by Companion Animal Type
12.3.8.4.7 Australia Companion Animal Diagnostics Market, by End User
12.3.8.5 South Korea
12.3.8.5.1 Overview
12.3.8.5.2 South Korea Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.5.3 South Korea Companion Animal Diagnostics Market, by Technique
12.3.8.5.3.1 South Korea: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.3.8.5.3.2 South Korea: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.3.8.5.3.3 South Korea: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.3.8.5.4 South Korea Companion Animal Diagnostics Market, by Product
12.3.8.5.5 South Korea Companion Animal Diagnostics Market, by Application
12.3.8.5.6 South Korea Companion Animal Diagnostics Market, by Companion Animal Type
12.3.8.5.7 South Korea Companion Animal Diagnostics Market, by End User
12.3.8.6 Rest of Asia Pacific
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.3.8.6.3 Rest of Asia Pacific Companion Animal Diagnostics Market, by Technique
12.3.8.6.3.1 Rest of Asia Pacific: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.3.8.6.3.2 Rest of Asia Pacific: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.3.8.6.3.3 Rest of Asia Pacific: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.3.8.6.4 Rest of Asia Pacific Companion Animal Diagnostics Market, by Product
12.3.8.6.5 Rest of Asia Pacific Companion Animal Diagnostics Market, by Application
12.3.8.6.6 Rest of Asia Pacific Companion Animal Diagnostics Market, by Companion Animal Type
12.3.8.6.7 Rest of Asia Pacific Companion Animal Diagnostics Market, by End User
12.4 Middle East & Africa Companion Animal Diagnostics Market, Revenue And Forecast to 2030
12.4.1 Overview
12.4.2 Middle East & Africa Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.3 Middle East & Africa Companion Animal Diagnostics Market, by Technique
12.4.3.1 Middle East & Africa: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.4.3.2 Middle East & Africa: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.4.3.3 Middle East & Africa: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.4.4 Middle East & Africa Companion Animal Diagnostics Market, by Product
12.4.5 Middle East & Africa Companion Animal Diagnostics Market, by Application
12.4.6 Middle East & Africa Companion Animal Diagnostics Market, by Companion Animal Type
12.4.7 Middle East & Africa Companion Animal Diagnostics Market, by End User
12.4.8 Middle East & Africa Companion Animal Diagnostics Market by Country
12.4.8.1 South Africa
12.4.8.1.1 Overview
12.4.8.1.2 South Africa Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.8.1.3 South Africa Companion Animal Diagnostics Market, by Technique
12.4.8.1.3.1 South Africa: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.4.8.1.3.2 South Africa: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.4.8.1.3.3 South Africa: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.4.8.1.4 South Africa Companion Animal Diagnostics Market, by Product
12.4.8.1.5 South Africa Companion Animal Diagnostics Market, by Application
12.4.8.1.6 South Africa Companion Animal Diagnostics Market, by Companion Animal Type
12.4.8.1.7 South Africa Companion Animal Diagnostics Market, by End User
12.4.8.2 Saudi Arabia
12.4.8.2.1 Overview
12.4.8.2.2 Saudi Arabia Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.8.2.3 Saudi Arabia Companion Animal Diagnostics Market, by Technique
12.4.8.2.3.1 Saudi Arabia: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.4.8.2.3.2 Saudi Arabia: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.4.8.2.3.3 Saudi Arabia: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.4.8.2.4 Saudi Arabia Companion Animal Diagnostics Market, by Product
12.4.8.2.5 Saudi Arabia Companion Animal Diagnostics Market, by Application
12.4.8.2.6 Saudi Arabia Companion Animal Diagnostics Market, by Companion Animal Type
12.4.8.2.7 Saudi Arabia Companion Animal Diagnostics Market, by End User
12.4.8.3 UAE
12.4.8.3.1 Overview
12.4.8.3.2 UAE Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.8.3.3 UAE Companion Animal Diagnostics Market, by Technique
12.4.8.3.3.1 UAE: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.4.8.3.3.2 UAE: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.4.8.3.3.3 UAE: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.4.8.3.4 UAE Companion Animal Diagnostics Market, by Product
12.4.8.3.5 UAE Companion Animal Diagnostics Market, by Application
12.4.8.3.6 UAE Companion Animal Diagnostics Market, by Companion Animal Type
12.4.8.3.7 UAE Companion Animal Diagnostics Market, by End User
12.4.8.4 Rest of Middle East & Africa
12.4.8.4.1 Overview
12.4.8.4.2 Rest of Middle East & Africa Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.4.8.4.3 Rest of Middle East & Africa Companion Animal Diagnostics Market, by Technique
12.4.8.4.3.1 Rest of Middle East & Africa: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.4.8.4.3.2 Rest of Middle East & Africa: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.4.8.4.3.3 Rest of Middle East & Africa: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.4.8.4.4 Rest of Middle East & Africa Companion Animal Diagnostics Market, by Product
12.4.8.4.5 Rest of Middle East & Africa Companion Animal Diagnostics Market, by Application
12.4.8.4.6 Rest of Middle East & Africa Companion Animal Diagnostics Market, by Companion Animal Type
12.4.8.4.7 Rest of Middle East & Africa Companion Animal Diagnostics Market, by End User
12.5 South & Central America Companion Animal Diagnostics Market, Revenue And Forecast to 2030
12.5.1 Overview
12.5.2 South & Central America Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.5.3 South & Central America Companion Animal Diagnostics Market, by Technique
12.5.3.1 South & Central America: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.5.3.2 South & Central America: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.5.3.3 South & Central America: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.5.4 South & Central America Companion Animal Diagnostics Market, by Product
12.5.5 South & Central America Companion Animal Diagnostics Market, by Application
12.5.6 South & Central America Companion Animal Diagnostics Market, by Companion Animal Type
12.5.7 South & Central America Companion Animal Diagnostics Market, by End User
12.5.8 South & Central America Companion Animal Diagnostics Market by Country. 194
12.5.8.1 Brazil
12.5.8.1.1 Overview
12.5.8.1.2 Brazil Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.5.8.1.3 Brazil Companion Animal Diagnostics Market, by Technique
12.5.8.1.3.1 Brazil: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.5.8.1.3.2 Brazil: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.5.8.1.3.3 Brazil: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.5.8.1.4 Brazil Companion Animal Diagnostics Market, by Product
12.5.8.1.5 Brazil Companion Animal Diagnostics Market, by Application
12.5.8.1.6 Brazil Companion Animal Diagnostics Market, by Companion Animal Type
12.5.8.1.7 Brazil Companion Animal Diagnostics Market, by End User
12.5.8.2 Argentina
12.5.8.2.1 Overview
12.5.8.2.2 Argentina Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.5.8.2.3 Argentina Companion Animal Diagnostics Market, by Technique
12.5.8.2.3.1 Argentina: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.5.8.2.3.2 Argentina: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.5.8.2.3.3 Argentina: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.5.8.2.4 Argentina Companion Animal Diagnostics Market, by Product
12.5.8.2.5 Argentina Companion Animal Diagnostics Market, by Application
12.5.8.2.6 Argentina Companion Animal Diagnostics Market, by Companion Animal Type
12.5.8.2.7 Argentina Companion Animal Diagnostics Market, by End User
12.5.8.3 Rest of South & Central America
12.5.8.3.1 Overview
12.5.8.3.2 Rest of South & Central America Companion Animal Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.5.8.3.3 Rest of South & Central America Companion Animal Diagnostics Market, by Technique
12.5.8.3.3.1 Rest of South & Central America: Companion Animal Diagnostics Market, by Immunodiagnostics, 2020–2030 (US$ Million)
12.5.8.3.3.2 Rest of South & Central America: Companion Animal Diagnostics Market, by Clinical Biochemistry, 2020–2030 (US$ Million)
12.5.8.3.3.3 Rest of South & Central America: Companion Animal Diagnostics Market, by Molecular Diagnostics, 2020–2030 (US$ Million)
12.5.8.3.4 Rest of South & Central America Companion Animal Diagnostics Market, by Product
12.5.8.3.5 Rest of South & Central America Companion Animal Diagnostics Market, by Application
12.5.8.3.6 Rest of South & Central America Companion Animal Diagnostics Market, by Companion Animal Type
12.5.8.3.7 Rest of South & Central America Companion Animal Diagnostics Market, by End User
13. Companion Animal Diagnostics Market Industry Landscape
13.1 Overview
13.1.1 Recent Developments
14. Company Profiles
14.1 Demeditec Diagnostics GmbH
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ARI Medical Technology Co Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Tianjin LOCMEDT Technologies Co Ltd
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Heska Corp
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Innovative Diagnostics SAS
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 i-SENS Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Universal Biosensors Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Immunology Consultants Laboratory Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Zoetis Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Elabscience Biotechnology Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The companion animal diagnostics market is expected to grow from US$ 3.139 billion in 2022 to US$ 6.303 billion by 2030; it is anticipated to record a CAGR of 9.1% from 2022 to 2030.

The companion animal diagnostics products takes care of the diagnosis of different of diseases in the pet animals. These products deals with the epidemiology and pathogenesis of the domestic animal and prevents further complications with health of the pet as well as the owner. These products are normally used for the animals like cats, dogs, horses. The companion animal diagnostics market size is expanding with the rising cases of infectious diseases and growing awareness about the use of point-of-care diagnostics for the detection of animal diseases. Point-of-care diagnostics (POCDs) are simple, rapid, and portable diagnostic devices that can detect the disease status at the field level. In recent years, real-time PCR (qPCR) has been transitioned into a POCD platform. These fully automated platforms combine nucleic acid extraction, thermal cycling, and on-site reporting results. For instance, MiniLab from Enigma Diagnostics is a molecular diagnostic platform of 10–35 kg that is carried at the field level and used for validating African swine fever virus, classical swine fever virus, avian influenza virus, and foot-and-mouth disease virus for research purposes. The genesig detection kits of Primerdesign Ltd, UK, supply lyophilized qPCR assay kits for the diagnosis of 62 bovine, 42 equine, 47 porcine, 60 avian, 40 canine, and 26 feline pathogens for research purposes.

Upsurge in Pet Spending Drives the Growth the Companion Animal Diagnostics Market

A large number of pet owners spend significantly on animal healthcare, particularly on veterinary care, diagnostics, and pharmaceuticals. Pet wellness and preventive diagnostic testing is still in its early stages. Animals can suffer from chronic illnesses such as arthritis, cancer, and allergies, similar to humans. Chronic diseases in pets have become more prevalent, which has a significant impact on people’s spending on their pets’ well-being and health. According to estimates from the American Veterinary Medical Association, 1 in 4 dogs is likely to experience neoplasia at some point in its life. Moreover, nearly half of the dogs would develop cancer after the age of 10. According to the American Pet Products Association, Americans spent US$ 136.8 billion on their pets in 2022, which was 10.68% higher than the amount spent in 2021 (US$ 123.6 billion). Thus, the growing prevalence of chronic diseases has become a more significant factor in the increase in pet spending. For instance, according to HealthforAnimals globally, an estimated US$ 4.6 billion was spent on companion animal diagnostics in 2022.

Figure: Pet Industry Expenditures in US, 2012–2021

Source: American Pet Products Association's 2021–2022 National Pet Owners Survey

The companion animal diagnostics market is divided on the basis of technique, product, application, companion animal type, end user, and geography. Based on technique, the companion animal diagnostics market is segmented into immunodiagnostics, clinical biochemistry, hematology, urinalysis, molecular diagnostics, and others. The immunodiagnostics segment is sub-segmented into lateral flow assays, ELISA tests, allergen-specific immunodiagnostic tests, and immunoassay analyzers. The clinical biochemistry segment is further categorized into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis. Based on product, the companion animal diagnostics market is bifurcated into instruments and consumables. Based on application, the companion animal diagnostics market is segmented into bacteriology, clinical pathology, virology, parasitology, and others. Based on companion animal type, the companion animal diagnostics market is segmented into dogs, cats, horses, and others. Based on end user, the companion animal diagnostics market is segmented into diagnostic laboratories, veterinary hospitals and clinics, and research institutes and universities..

Based on geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the companion animal diagnostics market. The growth of the market in the region is due to rising government support for research and development activities in veterinary medicine, growing technological advancements that are resulting in various market consolidations, and rising adoption of pet animals across countries in North America. In addition, the presence of various market leaders in the companion animal diagnostics market is projected to influence the market growth positively during the forecast period. The companion animal diagnostics market in the US is expected to be the largest in North America. The growth of the market in the country is determined by factors such as a technologically advanced team in research and development of the veterinary sector and the presence of numerous animal health centers. Besides this, an increase in the adoption rate of pet animals and rising concern about maintaining the health of pets further promote the market growth. According to the Humane Society of the United States, an estimated 69 million and 45.4 million households owned at least one dog and cat in 2021 and 2022, respectively. As per the American Pet Products Association, Americans spent US$ 136.8 billion on their pets in 2022, a 10.68% increase from 2021 (i.e., US$ 123.6 billion).

In the US, specific veterinary diagnostics are regulated and dependent on the US Department of Agriculture-Center for Veterinary Biologics (USDA-CVB) for approval. These involve veterinary diagnostic kits intended to diagnose pathogens in animals undergoing treatment. USDA-CVB are point-of-care diagnostics for testing feline leukemia virus (FeLV), canine parvovirus, canine heartworm, and other viruses. The National Veterinary Services Laboratories provide diagnostics services for animals, and it offers a wide range of diagnostic services and information centered around the diagnosis of domestic and foreign animal diseases. The laboratory is also involved in the support of disease control and eradication programs. It produces reagents for diagnostic testing and offers training and laboratory certification. Similarly, there are presence other private laboratories affiliated to the American Association of Veterinary Laboratory Diagnosticians. For instance, the Wisconsin Veterinary Diagnostic Laboratory offers a broad range of diagnostic services to the production, companion, and exotic animal industries.

The presence of strong players in the US is further augmenting the market growth. For instance, Zoetis Inc. is among the market leaders involved in the development, manufacturing, and marketing of veterinary point-of-care diagnostic instruments and consumables. It also offers immunodiagnostic products to help detect viruses, bacteria, antibodies to viruses, and bacteria through antigen–antibody reactions.

The market for companion animal diagnostics in Canada is expected to grow due to the well-developed and well-structured healthcare system. The Canadian government supports the veterinary sector by implementing regulations for better services. For instance, under guidelines 4.10E of the Regulation of Veterinary Biologics in Canada, the Canadian Centre for Veterinary Biologics (CCVB) regulatory program for veterinary biologics (VB) has been implemented. The authority of the Health of Animals Act and Regulations imposed the program. The VB regulatory program aims to protect the health of Canadian animals, such as domestic livestock, poultry, companion animals, wildlife, and aquatic species. In addition, it aims to protect public health and food safety by controlling indigenous animal diseases and preventing the spread of foreign animal diseases.

Similarly, increasing initiatives by the Canadian government are further propelling the market growth in the country. For instance, Animal Health Canada is involved in strengthening Canada’s capacity for animal disease prevention and animal health management. In addition, Antech Diagnostics, a division of Mars Petcare, has acquired Biovet, a Canadian biotechnology company that specializes in animal health and agro-industry diagnostics. The acquisition is expected to expand Antech Diagnostic’s research capabilities and access for veterinarians throughout Canada. Furthermore, an increase in the prevalence of various zoonotic diseases, growing technological advancements, and increasing pet ownership are the factors propelling the market growth in Canada.

American Horse Council, Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and National Council of Societies for the Prevention of Cruelty to Animals (NSPCA) are a few key primary and secondary sources referred to while preparing the report on the companion animal diagnostics market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（diagnostic）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（diagnostic）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?